Serotonin syndrome associated with concomitant tramadol and linezolid therapy: a case report and literature review
Frontiers in Pharmacology · 29.05.2026 · 17
DOI: 10.3389/fphar.2026.1825964 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.05.2026. Verfasst von Huixin Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, North China University of Science and Technology Afffliated Hospital, Tangshan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Serotonin syndrome (SS) is a potentially life-threatening adverse drug reaction resulting from excessive serotonergic activity in the central and peripheral nervous systems. Tramadol produces analgesia through μ-opioid receptor agonism while also inhibiting the reuptake of serotonin and norepinephrine. Linezolid an oxazolidinone antibacterial agent, possesses reversible, non-selective monoamine oxidase inhibitory activity. Through distinct pharmacological mechanisms, both agents enhance serotonergic neurotransmission and may theoretically increase the risk of SS when used concomitantly. We report the case of an elderly woman who developed serotonin syndrome shortly after receiving tramadol and linezolid for ischemic lower-limb pain complicated by severe infection. The patient fulfilled the Hunter diagnostic criteria, presenting with hyperthermia, tremor, myoclonus, hyperreflexia, muscle rigidity, diaphoresis, and flushing. The symptoms resolved rapidly after discontinuation of the suspected medications and initiation of supportive treatment. Although several real-world studies have suggested that the overall incidence of SS associated with concomitant linezolid and serotonergic agents is relatively low, this report highlights that individualized risk assessment remains essential in elderly patients with multiple comorbidities and polypharmacy. Careful evaluation of potential drug interactions and close clinical monitoring are therefore warranted when anti-infective and analgesic therapies with serotonergic properties are administered concurrently.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, North China University of Science and Technology Afffliated Hospital, Tangshan, China.
- Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zitieren
APA
Zhao, H., Liu, K., Zheng, Y., & Ni, L. (2026). Serotonin syndrome associated with concomitant tramadol and linezolid therapy: a case report and literature review. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1825964
Vancouver
Zhao H, Liu K, Zheng Y, Ni L. Serotonin syndrome associated with concomitant tramadol and linezolid therapy: a case report and literature review. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1825964
BibTeX
@article{Zhao2026,
author = {Zhao, Huixin and Liu, Kun and Zheng, Yuehong and Ni, Leng},
title = {Serotonin syndrome associated with concomitant tramadol and linezolid therapy: a case report and literature review},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1825964}
}
EUVIMED